Skip to main content
EarningsCallAI
TMO

Thermo Fisher Scientific

Healthcare

NEUTRAL(LOW)

Operator Signal: NEUTRAL

Steady-state performance. No major expansion or contraction signals, business as usual.

N/A
Latest Revenue
N/A
Revenue Growth (YoY)
$4.43
Latest EPS
$1.7B
Latest Net Income

Quarterly Earnings History

QuarterRevenueNet IncomeEPS
Q1 2026N/A$1.7B$4.43
Q3 2025N/A$1.6B$4.27
Q2 2025N/A$1.6B$4.28
Q1 2025N/A$1.5B$3.98
Q3 2024N/A$1.6B$4.25
Q2 2024N/A$1.5B$4.04
Q1 2024N/AN/A$3.46
Q3 2023N/AN/A$4.42

What This Means for Operators

Thermo Fisher Scientific is in steady-state mode. Revenue is relatively flat quarter-over-quarter, which means no major expansion or contraction signals. Business as usual.

Steady doesn't mean irrelevant. TMO's stability tells you the underlying market is mature. If you're building in this space, growth will come from taking share, not riding a wave.

Data from SEC EDGAR. View original filings: Thermo Fisher Scientific SEC Filings

Frequently Asked Questions

Thermo Fisher Scientific (TMO) currently has a NEUTRAL operator signal with LOW confidence. This signal is based on quarterly revenue trends and earnings patterns across 8 quarters of data.

Thermo Fisher Scientific's latest reported revenue is not yet available. Latest EPS was $4.43.

Based on 8 quarters of earnings data, Thermo Fisher Scientific shows a NEUTRAL signal. Revenue is relatively flat, indicating stability.

Thermo Fisher Scientific's quarterly (10-Q) and annual (10-K) filings are available on SEC EDGAR. We analyze these filings to extract revenue, EPS, and net income data for our operator signal calculations.

Sources: SEC EDGAR
Last updated:

Operator signals are derived from quarterly revenue trends, EPS patterns, and net income direction across multiple quarters. Signals indicate momentum direction, not stock recommendations.